跳至主要内容
临床试验/CTRI/2024/04/066061
CTRI/2024/04/066061尚未招募1 期

A Randomized Controlled Clinical Study On Add-On Effect Of Bhringaraj Yashtimadhu Siddha Taila Pratimarsh Nasya In Simple Myopia

Dr Shruti S Karade1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年5月1日最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Improvement of visual acuity based on LOGMAR chart.

研究概览

简要总结

Myopia is the commonest type of refractive error affecting the general population globally. In myopia, parallel rays of light coming from infinity are focused in front of retina when accommodation is at rest and therefore, it is also referred to as ‘Short Sightedness’.In previous studies, no effective Ayurvedic treatment in Simple Myopia has been discovered yet. Also, Netra Tarpana and Abhyantar Sevana modalities have been used already. Bhringaraj is ‘Netrya’ and Yashtimadhu is ‘Chakshushya’ according to Ayurvedic texts and both of these, if given in Pratimarsh Nasya form can prove to be effective in Myopia. Pratimarsh Nasya does not vitiate any doshas.The study is being undertaken, after reviewing that Pratimarsh Nasya has never been used as a modality in treating Simple Myopia till date and it is cost effective as well.

研究设计

研究类型
Interventional
分配方式
Other
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 40.00 Year(s)(—)
性别
All

入选标准

  • 1.Patients between the age group of 18 to 40 years will be included.
  • 2.Patients will be selected irrespective of gender, socioeconomic status and religion.
  • 3.Patients diagnosed with Simple Myopia and having refractive power between -0.5D to -6.00D.

排除标准

  • 1.Patients suffering from high myopia and pathological myopia 2.Patients suffering from any retinal pathologies, ocular surface pathologies 3.Patients having congenital anomalies 4.One eyed patient.

结局指标

主要结局

Improvement of visual acuity based on LOGMAR chart.

时间窗: Baseline, 15th, 30th, 45th day

Reduction of refractive error in the trial group.

时间窗: Baseline, 15th, 30th, 45th day

次要结局

  • Reduction in the symptoms of headache, eye strain and blurring of(vision in the trial group.)

研究者

发起方
Dr Shruti S Karade
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Shruti S Karade

Bharati Vidyapeeth Deemed to be University College of Ayurved

研究点 (1)

Loading locations...

相似试验